ICAM1 and Alzheimer disease: It is noteworthy that AD brains show increased expression of ICAM‐1 in astrocytes surrounding Aβ plaques,61, 62 suggesting that ICAM‐1 could be a potential downstream target of the Aβ42/fibrinogen complex.